Skip to Main Content

Author Details

Aracelis Z Torres
Bloomberg School of Public Health, Johns Hopkins
2018
22
12
PMIDPaper TitleJournal TitlePublished Year
36928508Identifying the mechanism of missingness for unspecified diabetic retinopathy disease severity in the electronic health record: an IRIS® Registry analysis.J Am Med Inform Assoc2023
37064590Measuring Ambulatory Racial and Ethnic Neurologic Disparities With the Axon Registry.Neurol Clin Pract2023
36790088The Association Between Baseline Hepatic or Renal Function and Clinical Outcomes for Patients With Non-Small Cell Lung Cancer Treated With a PD-1/PD-L1 Blocking Antibody Using Real-World and Trial Data.Clin Pharmacol Ther2023
36626210Emulating VIEW 1 and VIEW 2 Clinical Trial Outcome Data Using the American Academy of Ophthalmology IRIS Registry.Ophthalmic Surg Lasers Imaging Retina2023
36718093Simultaneous adjustment of uncontrolled confounding, selection bias and misclassification in multiple-bias modelling.Int J Epidemiol2023
34197637Emulating Control Arms for Cancer Clinical Trials Using External Cohorts Created From Electronic Health Record-Derived Real-World Data.Clin Pharmacol Ther2022
35440047Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data.Blood Cancer J2022
35430670Analysis of a Real-World Progression Variable and Related Endpoints for Patients with Five Different Cancer Types.Adv Ther2022
36812509Best practices in the real-world data life cycle.PLOS Digit Health2022
32464188Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study.Chest2020
32011529Real-World Dosing Patterns and Outcomes of Patients With Metastatic Pancreatic Cancer Treated With a Liposomal Irinotecan Regimen in the United States.Pancreas2020
33094874Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors.Oncologist2020
30591549Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval.Oncologist2019
31381142Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer.Cancer2019
31335166An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non-Small-Cell Lung Cancer.JCO Clin Cancer Inform2019
30964529Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.JAMA2019
30873729An evaluation of the impact of missing deaths on overall survival analyses of advanced non-small cell lung cancer patients conducted in an electronic health records database.Pharmacoepidemiol Drug Saf2019
30421624Treatment patterns, duration and outcomes of pemetrexed maintenance therapy in patients with advanced NSCLC in a real-world setting.Curr Med Res Opin2019
29317551Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval.Oncologist2018
29756355Development and Validation of a High-Quality Composite Real-World Mortality Endpoint.Health Serv Res2018
30425965Evaluating Neighborhood Correlates and Geospatial Distribution of Breast, Cervical, and Colorectal Cancer Incidence.Front Oncol2018
30012876Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors.Oncologist2018
  • 1 - 22 of 22

Recommended Authors

Mayo Clinic
Career Start Year 2018
Number of shared co-authors 0
David Geffen School of Medicine at the University of California los angeles
Career Start Year 2017
Number of shared co-authors 0
College of Human Medicine, Michigan State University
Career Start Year 2015
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2015
Number of shared co-authors 0
University of Texas Health San Antonio
Career Start Year 2013
Number of shared co-authors 0
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 1
San Diego State University School of Public Health
Career Start Year 2011
Number of shared co-authors 1
Department of Pharmacy, 5Peter MacCallum Cancer Centre
Career Start Year 2011
Number of shared co-authors 0
HealthPartners Institute
Career Start Year 2011
Number of shared co-authors 1
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 2010
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
University of Michigan School of Public Health ann arbor
Career Start Year 2009
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2009
Number of shared co-authors 1
Georgetown University
Career Start Year 2008
Number of shared co-authors 0
College of Medicine, University of Kentucky, Kentucky Kentucky Cancer Registry
Career Start Year 2007
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 0
Rush University Cancer Center, Rush University Medical Center
Career Start Year 2007
Number of shared co-authors 0
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 0
117902Beijing TongRen Hospital, Capital Medical University
Career Start Year 2004
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 0
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 0
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 2
Stanford University
Career Start Year 1997
Number of shared co-authors 0
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Memorial-Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 2
Odette Cancer Centre
Career Start Year 1996
Number of shared co-authors 1
National Cancer Institute
Career Start Year 1983
Number of shared co-authors 1

Collaborators

Oncology Center of Excellence
Co-authored papers 3
Oncology Center of Excellence
Co-authored papers 2
Northwestern University Feinberg School of Medicine
Co-authored papers 2
Foundation Medicine
Co-authored papers 1
American Academy of Ophthalmology
Co-authored papers 1
Co-authored papers 1
Mayo Clinic, MN Mayo Clinic Platform
Co-authored papers 1
Co-authored papers 1
Institute of Psychiatry, King's College London
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
Co-authored papers 1
Imperial College London
Co-authored papers 1
Co-authored papers 1
University of Cincinnati
Co-authored papers 1
Royal Free Hospital
Co-authored papers 1
Co-authored papers 1
Guy's and St Thomas' NHS Foundation Trust
Co-authored papers 1
Genesis Research LLC
Co-authored papers 1
Harvard T.H. Chan School of Public Health, MIT
Co-authored papers 1
Co-authored papers 1
University of Iowa, School of Public Health
Co-authored papers 1
Co-authored papers 1
Fielding School of Public Health, University of California los angeles
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
T.H. Chan School of Public Health, Harvard University
Co-authored papers 1
National Hospital for Neurology and Neurosurgery
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Co-authored papers 1
Imperial College London
Co-authored papers 1
Injury Prevention Research Center, University of North Carolina
Co-authored papers 1